Earnings

  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic adds 2 board seats, forms special committees

    CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott Investment Management.

    By • Aug. 19, 2025
  • Vicarious Surgical's robotic system.
    Image attribution tooltip
    Courtesy of Vicarious Surgical
    Image attribution tooltip

    Vicarious Surgical delays robot timeline

    Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by the end of the year.

    By • Aug. 13, 2025
  • New Masimo CEO Katie Szyman wears a navy blue jacket and white shirt.
    Image attribution tooltip
    Permission granted by Masimo
    Image attribution tooltip

    Masimo appoints several senior execs, resolves cyber incident

    The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but investors have raised questions about the status of a partnership with Philips.

    By • Aug. 8, 2025
  • Close up of a knee implant, showing the stem, which includes a gray extension.
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer is latest medtech firm to lower expected tariff hit

    CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million to $80 million.

    By • Aug. 7, 2025
  • A modern industrial building with beige and white walls and large blue-tinted glass windows. The name “Stryker” is mounted in black letters on the upper portion of the building. A white smokestack protrudes from the roof, and the sky is light and partly cloudy.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Stryker lowers expected tariff impact to $175M

    The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing strength in procedure demand.

    By • Aug. 1, 2025
  • Modern office building with tall glass windows and palm trees lining the entry drive. A large white and green sign in the foreground reads “Dexcom” with the number “6350” below. Surrounding the sign are colorful landscaping features including small bushes, flowers, and a mulched bed. Cars and flags are visible in the background.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Dexcom raises sales expectations, discusses G8 plans

    Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and over-the-counter devices to drive future growth.

    By • July 31, 2025
  • In an aerial view, container ships sit docked at the Port of Oakland on December 09, 2024 in Oakland, California.
    Image attribution tooltip
    Justin Sullivan / Staff via Getty Images
    Image attribution tooltip
    Earnings & Tariffs

    Medtech firms slash expected tariff charges

    This earnings season, top medical device companies have dramatically reduced their expectations for tariff impacts in 2025. Check out MedTech Dive’s coverage.

    By • July 30, 2025
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip
    Earnings & Tariffs

    Siemens Healthineers cuts tariff impact after trade talk breakthrough

    The company predicted a full-year impact of 200 million to 250 million euros, down from its previous forecast of up to 300 million euros.

    By • July 30, 2025
  • Deira Ward (L) and Lisa Bates (R) work at a computer near a large PCR analysis machine at a Quest Diagnostics testing lab in Indianapolis, Indiana. The lab is capable of processing up to 3700 tests pe
    Image attribution tooltip
    Jon Cherry via Getty Images
    Image attribution tooltip

    Quest, Labcorp downplay ‘Big Beautiful Bill’ impact

    Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and domestic policy bill, including cuts to Medicaid, will be minimal.

    By • July 29, 2025
  • A Philips factory
    Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip
    Earnings & Tariffs

    Philips lowers expected tariff hit to 150M to 200M euros

    The company previously forecast an up to 300 million euro tariff impact in 2025 before the U.S. struck agreements with China and the European Union.

    By • July 29, 2025
  • Edwards Lifesciences' Sapien 3 Ultra heart valve replacement system is shown with the valve expanded by a balloon.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards loses longtime TAVR leader Larry Wood

    Wood, who helped build Edwards’ TAVR business, will become CEO of Procept BioRobotics. Edwards also raised its sales and earnings outlook for the full year.

    By • July 25, 2025
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip
    Earnings & Tariffs

    Boston Scientific halves expected tariff hit

    The company now expects a tariff charge of $100 million this year, down from a $200 million impact forecast on the company’s first-quarter earnings call.

    By • July 23, 2025
  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    Earnings & Tariffs

    Intuitive Surgical tempers tariff impact expectations

    Executives also addressed Medicaid concerns and competition from third-party suppliers of remanufactured surgical instruments on an earnings call.

    By • July 23, 2025
  • Abbott BinaxNOW home COVID-19 test
    Image attribution tooltip

    Abbott

    Image attribution tooltip
    Earnings & Tariffs

    Abbott lowers sales forecast on diagnostics decline, US funding cuts

    Medical device sales remained a bright spot for the company, however, with more than 20% growth in diabetes devices.

    By • July 17, 2025
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip
    Earnings & Tariffs

    ‘We are not rolling over’: J&J electrophysiology unit rebounds amid PFA rivalry

    The division returned to growth in the second quarter after declining over the previous three months. Now, can the healthcare giant catch up with its rivals in pulsed field ablation?

    By • July 16, 2025
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip
    Trump tariffs

    J&J may take a softer tariff hit after US-China pause, CFO says

    Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with China and Europe and Section 232 investigations are ongoing.

    By • June 4, 2025
  • A person looks at a smartwatch while walking past packaged produce.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Why Medtronic plans to spin out its diabetes business

    While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on segments with higher margins.

    By • May 22, 2025
  • Shipping containers are stacked on a container ship at the Port of Los Angeles, as a truck passes above in front of the snow-capped San Gabriel Mountains, on February 7, 2023 in Los Angeles.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip
    Trump tariffs

    Cost cuts, production shifts: How medtech firms are managing tariffs

    Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade standoff.

    By • May 22, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic plans to spin off diabetes business within 18 months

    CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech competitor.

    By • May 21, 2025
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom CEO says CGMs fit MAHA agenda ‘very nicely’; Tandem preps for new products

    In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

    By • May 16, 2025
  • UnitedHealth Group CEO Andrew Witty
    Image attribution tooltip
    Kent Nishimura/Getty Images via Getty Images
    Image attribution tooltip

    Andrew Witty steps down as UnitedHealth CEO

    Witty’s departure was surprising, though it follows a sharp downturn in the healthcare juggernaut’s financial outlook. He is being replaced by Stephen Hemsley, the chair of UnitedHealth’s board and a previous chief executive.

    By Rebecca Pifer • May 13, 2025
  • President Donald Trump displays a chart showcasing coming tariff rates at the White House on April 2, 2025.
    Image attribution tooltip
    Chip Somodevilla via Getty Images
    Image attribution tooltip
    Earnings & Tariffs

    Solventum’s projected $100M tariff hit prevents earnings increase

    CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its supply chains.

    By • May 12, 2025
  • Professional photo of Ashley McEvoy
    Image attribution tooltip
    Permission granted by Insulet
    Image attribution tooltip

    New Insulet CEO Ashley McEvoy sets priorities

    The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.

    By • May 9, 2025
  • The hand of a scientist in a blue glove runs a test on an Illumina sequencing machine.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    SEC ends probe of Illumina’s Grail acquisition

    The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

    By • May 9, 2025
  • A picture of Masimo's headquarters building.
    Image attribution tooltip
    Mario Tama / Staff via Getty Images
    Image attribution tooltip

    Masimo says cyberattack has impacted its ability to fulfill orders

    The maker of patient monitoring devices is working to bring the affected portions of its network back online and restore normal business operations.

    By David Jones • May 8, 2025